About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,239 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,239 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4021-4040 of 4,239 trials

CompletedOxytocin and CBSST for People With SchizophreniaA significant proportion of people with schizophrenia are characterized by impaired ability to socially engage with others, which may reflect social aversion secondary to…NCT01752712·San Diego, California and 1 other TerminatedA TAK-831-1001, Single and Multiple Rising Dose Study in Healthy ParticipantsThe purpose of this study is to determine the safety, tolerability and pharmacokinetics (PK) of single and multiple rising doses of TAK-831 in healthy participants.NCT02566759·London CompletedMetformin Treatment on Cognitive Impairment of SchizophreniaIn this study, the investigators will investigate the effect and the underlying mechanism of metformin treatment on cognitive impairment in individuals with schizophrenia.NCT05838573·Changsha, Hunan and 3 others

Related Searches

Data from ClinicalTrials.govTerms

CompletedD-serine Monotherapy for SchizophreniaA first generation of clinical studies, performed during the last decade, demonstrates that adjuvant treatment with compounds that enhance NMDAR-mediated neurotransmission due to…NCT00816894·Jerusalem

CompletedMetabolic Syndrome in Patients With First-episode SchizophreniaThe metabolic syndrome (MetS) is highly prevalent in patients with schizophrenia and is a major risk factor of type-2 diabetes, cardiovascular disease and early death.NCT00957294·Aarhus, Risskov

Not yet recruitingEfficacy and Safety of Temporal Interference Stimulation in Treatment-Resistant Schizophrenia: An Exploratory Study.This exploratory study aims to evaluate the preliminary efficacy and safety of temporal interference (TI) stimulation in patients with treatment-resistant schizophrenia (TRS).NCT07773831

CompletedIntramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaThe aim of this study was to compare the efficacy and safety of intramuscular 10 mg olanzapine versus intramuscular 5 mg haloperidol plus lorazepam 2 mg in the treatment of acute…NCT00797277·Taipei

CompletedDopamine Function and Reward Processing In SchizophreniaBackground: \- Schizophrenia is associated with cognitive impairment in different parts of the brain, including those associated with learning and memory.NCT01035996·Baltimore, Maryland and 1 other

CompletedHuperzine for Cognitive and Functional Impairment in SchizophreniaHuperzine is a natural plant product with procognitive properties in patients with Alzheimer's disease. Cognitive difficulties hamper functioning in schizophrenia as well.NCT00963846·New Haven, Connecticut

Not yet recruitingMechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in SchizophreniaThe goal of this randomized, double-blind, placebo-controlled clinical trial with an open-label extension is to evaluate whether sulforaphane can improve negative symptoms and…NCT07652866·Changsha, China

Not yet recruitingA Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaSchizophrenia is a long-lasting and serious mental health disorder that affects about 1% of people worldwide.NCT07084831·Innsbruck and 15 others

CompletedModafinil as an Adjunctive on Cognitive Functioning in Patients With SchizophreniaPatients suffering from schizophrenia and schizophrenia spectrum psychosis frequently experience cognitive impairments.NCT00314639·Québec, Quebec

CompletedA Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia PatientsA multicenter, randomized, double-blind, triple-dummy, group-comparison study using placebo and nitrazepam as a comparative drug.NCT00374777·Chubu Region and 5 others

CompletedEfficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot StudyThe purpose of this study is: To investigate whether a treatment with quetiapine for six months in patients with first-episode psychosis may be effective in treating depressive…NCT00511277·Göttingen

Active not recruitingProbing the Cannabinoid System in Individuals With a Family History of PsychosisThe overall purpose of this study is to determine whether a family history of psychosis is associated with an altered cannabinoid system.NCT02102113·West Haven, Connecticut

CompletedNaltrexone and Bupropion Combination on Obese,Smoking Patients With SchizophreniaThe purpose of this research is to observe the efficacy of Naltrexone and Bupropion combination on weight loss and smoking cessation from baseline to week 24 compare to placebo.NCT02736474

CompletedStudy to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical AntipsychoticsThis is a randomized, double-blind, placebo-controlled, sequential cohort, ascending oral dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of…NCT02037074·Long Beach, California

UnknownA Mobile Application to Improve Case-management and Patient's Functioning in First Episode PsychosisFirst Episode Psychosis (FEP) includes perceptual distortions, delusions and cognitive impairment with severe consequences, such as suicidal behaviour.NCT04657380·Lyon, Auvergne-Rhône-Alpes

CompletedCognitive Remediation Therapy and SchizophreniaObjectives: The purpose of this study is to determine the impact of a new Cognitive Remediation Therapy (CRT) on cognition, social autonomy, symptoms and brain functioning in…NCT01078129·Bron

CompletedThe Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia PatientsAs a result of the positive and negative symptoms that occur in schizophrenia, patients with schizophrenia may experience negative emotions more frequently than individuals with…NCT05662137·Sinop

PreviousPage 202 of 212Next